In this review, we will focus on aldose reductase (AR), its possible link to the cardiovascular complications of diabetes mellitus and the potential impact of pharmacological inhibition of AR on cardiovascular complications of diabetes. Here, AKR1B1 is linked to diabetes mellitus.